chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced extreme exhaustion intermittently for 10 days after the vaccine. I also had some cold-chilling during that time.
itching; a rash type thing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: PRURITUS (non-serious), outcome "unknown", described as "itching"; RASH (non-serious), outcome "unknown", described as "a rash type thing".  Additional Information: Consumer spoke to someone with company named (withheld) who is a nurse, and he doesn't know what option, maybe 3, that he was supposed to dial regarding having possible side effects. He says he had a lot of itching and a rash type thing going on for quite a while. He says he has seen allergists and dermatologists and they can't seem to find any solutions. He says he had steroid shots, so he wanted to know if the people who manufactured the vaccine have come up with any solutions for this. He says he has heard of other people who have the same thing, he has been on the internet, and everything has side effects. Caller declines to provide Email Address. Caller clarifies he got the Pfizer COVID-19 vaccine, and his first dose was 20Jan2021 with LOT: EL3302. Caller says NDC/LOT/EXP were not written on his vaccine card for any doses. He says his second dose was 10Feb2021 of LOT: EN6201. He says his booster dose was LOT: FG3592 which was given on 02Oct2021. He provides unknown number from vaccine card: 1-7-217.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200503314 same reporter/drug/AE with different patient
Chills, could not walk, dizziness, red rash with soreness on left upper thigh
The patient recieved the second dose of Moderna vaccine on 5/10/2021, she called us today 6/3/2021, and reported that on third day after the shot , she had slight fever then she felt severe side effects: she lost smell and taste, headache, pain and swelling in joints and dizziness. The symtoms still last till now and we advised her to see her doctor right away.
This spontaneous prospective pregnancy case reported by a consumer, describes the occurrence of maternal exposure during pregnancy (vaccine exposure during pregnancy) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. Last menstrual period and estimated date of delivery not provided. On an unknown date, patient experienced maternal exposure during pregnancy (vaccine exposure during pregnancy). At the time of the report, maternal exposure during pregnancy (vaccine exposure during pregnancy) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications or treatment information reported. Patient is about 37 weeks pregnant. Most recent follow-up information incorporated above includes: On Mar 27, 2021: Follow-up received as no new information. Sender's comments: This is a case of product exposure during pregnancy with no associated AEs for this unknown age female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Received influenza vaccine on Nov 18 2002. Within  30 min developed a rash described as red blotches. No resp distress. Sought medical treatment. Continues to experience episodic outbreaks of rash. Chronic contact dermatitis vs Chronic urticaria
The patient has inflammation at the site, hot, and swelling from the shoulder to the elbow. The redness under the arm lasted 5 days.
She is experiencing a headache right now; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on 19Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was experiencing a headache right now after the first dose. She did take Tylenol and mentioned that she felt better. She was scheduled on 10May2021 for the second dose, she mentioned that she would not be available because she would be having a trip in a different state and her returning flight is in between of 10May to 16May2021. She wanted to know if she could reschedule it. The outcome of event headache was recovered.  No follow-up attempts are needed; information about batch/lot number cannot be obtained.
severemigraine; Felt nauseous; Muscle cramps in legs; Headache; This is a spontaneous report from a contactable consumer. A 17-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an intramuscular route of administration in the arm right on 20Apr2021 at 14:45 as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included adapalene (MANUFACTURER UNKNOWN) and benzoyl peroxide, clindamycin phosphate, 1-5% (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an intramuscular route of administration in the right arm on an unknown date in Mar2021 at 16:45 as a single dose for COVID-19 immunisation. On 20Apr2021 at 16:00, the patient had muscle cramps in her legs in the evening of the 2nd vaccination along with a headache. The following day on 21Apr2021, the patient woke up with a severe migraine and felt nauseous. She was not able to go to school and the headache persisted until the evening. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle cramps in legs, migraine and felt nauseous were recovered on an unknown date in Apr 2021 whereas the event headache was resolved on 21Apr2021.  No follow-up attempts are needed. No further information is expected.
This is a spontaneous report from a contactable consumer (patient). A patient, of unspecified age and gender, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not reported), via an unspecified route of administration, on an unspecified date, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. On an unspecified date, patient experienced extreme fatigue, lost all sense of smell, muscle and joint pain. The outcome of the events: unknown. The patient stated as follows: "I was vaccinated two weeks ago yesterday with the Pfizer first dose. Within 7 days I started feeling (you know it seems to be normal side effect) fatigue, extreme fatigue. Then I started getting muscle and joint pain, which lasted most of the week until Thursday, this last Thursday, today Sunday. Friday it was still there. It got better yesterday and today I am feeling much better. One of the things I noticed was on Thursday I lost all sense of smell. " The lot number for the vaccine, BNT162B2, not provided and will be requested during follow-up.
Patient came in on 12/6 with complaints of redness and swelling in right upper arm. Provider saw patient and diagnosed as cellulitis. Patient was also "kicked" by one of their cows on right arm. Patient was given antibiotics.
48 hours after vaccine administered pt developed swelling, redness, pain a site of injection (L) arm, difficulty lifting arm and feeling very sleepy and tired.
2 days after H1N1 vaccination developed URI for 2 weeks. On 11/9/09 felt burning on L side of face-Bell's palsy diagnosed. Given steroids, FAMVIR, and eye moistening drops. 11/20/09 Medical records received for date 11/10/09. DX: Bells Palsy. Presenting SX: c/o  facial numbness, eye burning.
Swollen lymph nodes at jaws; rash on stomach; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration in the right arm on 12Mar2021 11:00 AM (at the age of 62-years-old) as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 13Mar2021 13:00 PM, the patient experienced swollen lymph nodes at jaws and rash on stomach. It was unknown if treatment was received for the events. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The outcome of the events was not recovered.   No follow-up attempts are possible; information about the batch/lot number cannot be obtained. No further information is expected.
Noticed a swelling flare in my hands ( I have inflammatory arthritis, autoimmune disease), especially notable the day after the vaccine was given (4/15), which did improve over the following days but was still present somewhat when I saw my rheumatologist, Dr, in a scheduled followup appointment on 4/21/22.  She gave me a low dose Prednisone taper for 5 days which I started on 4/23/22 and it resolved the swelling by 4/27/22
Developed herpes zoster rash (positive zoster culture) down left leg x lower back.  Complaining of pain in left leg with limp.
After being administered the Rabavert vaccine on 02/18/22 the patient began experiencing itchiness on her arms and extremities followed by swelling of her lips on Sunday 02/20/22 and took Benadryl on Sunday and her symptoms resolved fully on sunday
The day after receiving my third dose, I started to have frequent chest pains. I would take the Equitrim and it would go away. It would come back within a day or two. I told my Oncologist and he wanted me to have an EKG and X-ray's. All tests came back normal. I still have the pains every couple of days, but I take my medication and it helps.
pt noticed itching @ inject site p/getting flu vac 1OCT93; rash on trunk, extremities approx 2 hrs p/vax; inject site sore, red & feverish; pt took DPH 5OCt92 to 6OCT92; rash going away today 6OCT93; pt did not see MD;
Pt seen 06/28/03 and received DTaP #5 and Hep A. DTaP #5 to right thigh and Hep A to left thigh. Went to ER 6/30/03 for reaction and received antibiotics.
Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------------------------------- HYPOXIA 4/18/2023 REACTIVE AIRWAY DISEASE, UNSPECIFIED
03/23/03 Temp of 100 to 100.3 times 2 days. 03/25/03 Afebrile. Developed rash over entire body, most notesable on face and torse.
Information had been received on 29-JUL-2015 from a female consumer via social media who reported that her 12 year old son was given the GARDASIL vaccine yesterday and had a seizure-like adverse reaction to it. The consumer reported, "We were told this is normal and happens 3-4 times a day by the administering nurse. I don't consider seizures to be customary or normal during vaccine administration. I assure you that if there are any negative, short or long-term impacts on my son's life, I will do everything within my means to ensure that this vaccine is removed from the market and that your company faces criminal charges." The outcome of the seizure-like adverse reaction was not reported. Upon internal review, seizure-like adverse reaction was determined to be medically significant. Additional information is not expected.
Pt was vaccinated on 3/16/2021 with J&J COVID 19 vaccine.  Pt developed increasing URI sx @ 4/5/2021. The symptoms progressed and she noticed that she was feeling more and more sob, fatigued, and had developed some mild cp.  She presented with a pulse ox of 94% on RA. No acute distress. Lung sounds diminished.
The patient had two orders of flu shots . There was a consent signed for the shot - I gave her on 10/08/21 a complete order and signed consent, explained to the patient that she would be getting the flu shot.  The patient verbalized that she would be receiving the flu shot, after the end of her treatment, the patient said that she had gotten the shot two days ago. On 10/06/21, on record it shows that there were two orders and the patient gave consent twice. Doctor informed and she ordered to  continue  follow up the patient. The patient did dialysis this week and the patient has denied  any symptoms. We will continue to follow up the patient
after injection I had some side affect and developed fever and took Tylenol, chills, and felt fatigue. It took 2 days I stayed in the bed. Felt lymph nodes when I touch my arm.  They were very uncomfortable. Applied warm compress in the area. on 5/18 I developed a rash on my armpit, the side of my bellybutton, my knee, my inner thighs, and through the shoulder blades.  Like cat and dog scratches.  I took anti itching medications. They itch.
According to pt's grandmother, the pt, who came in last May 8th, the child was apparently brought to ER, several days, post vax. The child who eventually transferred to hospital and subsequently, to a rehab center. No other information available, at this time. Diagnosis: hypovolemic shock, sepsis.  Follow up:  Ischemic brain injury; status post presumed meningoencephalopathy; interstitial nephropathy; sick-swallow incoordination.
Should have been given the Pfizer vaccine  for 2nd dose, was inadvertently given Moderna
Information has been received from a physician, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications were not provided. On 26-JUL-2018, the patient was inadvertently vaccinated with an expired unspecified dose of VARIVAX, lot number: M033906 with expiration date on 20-JUL-2018 (strength, dose number, anatomical location and route of administration were not reported), for prophylaxis (expired product administered). No adverse effect was reported.
I was diagnosed with POTS syndrome after multiple episodes of passing out and regular bouts of lightheadedness. The first episode was 2 days after my first COVID vaccine.
swelling all over his body for 4 days; developed hives; This is a spontaneous report from a contactable consumer (patient mother). This 12-years-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  Reporter was the mother of a 12 year old boy who received the Pfizer Covid vaccine. 24 hours after he developed hives and swelling all over his body for 4 days. He was seen in the emergency room. The outcome of the events was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Diarrhea, cramping, bloating noticed at time of waking up at 5:00 am.
sick diarrhea; Short of breath; dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in May2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: DYSPNOEA (non-serious) with onset 2022, outcome "unknown", described as "Short of breath"; DIZZINESS (non-serious) with onset 2022, outcome "unknown"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "sick diarrhea".  Additional information: It was reported that the patient had the covid shot in end of last month May and received a booster.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
constant severe pain on the left shoulder, and exact area of the flu shot.   I was unable to move my  arm in any direction, and the severe pains continued with sleepless nights for first 4 months.  Unable to tidy myself properly and had to request help even when changing my clothing.   Driving was a signifcant problem,  unable to do home chores, unable to lift anything above a few pounds; therefore food-shopping have continued to be an issue for me.   I used heat pad, tylenol, excedrin, and other rubbing oitments which just eased pains a bit.  I had a referral from my primary doctor to see an Orthopaedic Specialist, who  took, xtras, and referred me for an MRI -  01/09/23  - MRI      On my return to the Orthopaedic Specialist, I was administered a Cortisone Shot., which as he explained provides temporary relief.  He said surgerey is the next option. I was given referral for Physical Theraphy.  Physical Theraphy  -   01/20/2023  -   I had  session of Physical Shoulder exercises and and scheduled for  follow-up future appointments.
Around 8-10 hours after my second shot, I started to get joint pain in the arm I got the shot. It worsened over time as I was working the night shift and using the arm. Nearing midnight that same day, I started feeling feverish, and when I got home at 1:15am I got some water and tried to sleep, but it's 6 hours later and I haven't been able to sleep at all.
Pharmacy saying they don't think vaccine was refrigerated properly, would not be effective; Didn't know if it would be effective, they didn't know if it was refrigerated properly; Pharmacy saying they don't think vaccine was refrigerated properly, would not be effective; Didn't know if it would be effective, they didn't know if it was refrigerated properly; received the booster dose of the Pfizer covid 19 vaccine on 14Sep2021.; received the booster dose of the Pfizer covid 19 vaccine on 14Sep2021.; Had a slight reaction nothing really, we had a little chills like that; This is a spontaneous report from a contactable consumer. A 74-year-old female patient received third dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), via an unspecified route of administration, administered in Arm Right on 14Sep2021 (at the age of 74 year) as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously took BNT162B2 dose 1 and 2 on an unknown date for COVID-19 immunisation. Consumer stated that patient had two Pfizer shot for the vaccine, patient went on the 14Sep2021 to the Pharmacy for the booster shot (COVID 19 Vaccine). Patient had a slight reaction nothing really, had a little chills like that on Sep2021. Pharmacy saying that they don't think that it was refrigerated properly and may be would not be effective. The patient underwent lab tests and procedures which included blood test: unknown results on unspecified date. It was reported that no therapeutic measures were taken for the events experienced. At the time of reporting the outcome of the event was unknown.  The batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101301642 Same reporter/drug/AE, different patient
red rashes upper chest fron t and upper back, red rashes on neck and face dry mouth (no salaviya) excess was on face, on nose, and on ear fatigue and tiredoness loss of focus and memory loss declining vision
started fever approx 4 hrs p/vax which cont through next day on 2nd day p/vax had fine red rash over trunk went to clinic; dx scarlet fever;
PCR positive; PCR positive / COVID positive; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 27-year-old female patient received bnt162b2 (BNT162B2), administration date 24Dec2021 (Lot number: FF2589) at the age of 27 years as dose 3 (booster), single, administration date May2021 (Batch/Lot number: unknown) as dose 2, single and administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 25Feb2022, outcome "unknown", described as "PCR positive"; COVID-19 (medically significant) with onset 25Feb2022, outcome "unknown", described as "PCR positive / COVID positive". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (25Feb2022) positive, notes: Nasal Swab. Reporter mentioned that Seriousness criteria not Resulted in death, Life threatening, prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. Events reported as, Known COVID positive event 17Feb and then out to eat w/e of 19-20Feb so could have been there but PCR positive 25Feb with sx of cough ST and runny nose. Unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It is Unknown if Prior to vaccination, was the patient diagnosed with COVID-19. Since the vaccination, patient had been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events drug ineffective,COVID-19 and the use of suspect product BNT162B2 cannot be fully excluded.
violent diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (violent diarrhea) in a 94-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 1042120A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (violent diarrhea). At the time of the report, DIARRHOEA (violent diarrhea) had resolved.            The patient had loose stool for about 3 to 4 times.No concomitant medications reported.  No treatment medications provided by the reporter.   Action taken with mRNA-1273 in response to event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21 Jun 2021.Updated outcome of event from unknown to resolved.